Followed 184 Times Top-Rated Dividend Stocks Searched 744 Times

NYSE:ABBV

AbbVie Earnings Date, Estimates, & History

$107.07

-0.29 (-0.27 %)

(As of 09/24/2021 12:00 AM ET)

Add

Compare

Today's Range

$106.44

▼

$108.05

50-Day Range

$106.40

▼

$120.78

52-Week Range

$79.11

▼

$121.53

Volume5.45 million shs

Average Volume7.04 million shs

Market Capitalization$189.21 billion

P/E Ratio28.86

Dividend Yield4.84%

Beta0.82

Upcoming
Earnings Date
Oct. 29
Estimated

Actual EPS
(Jul. 29)
$3.11
Beat By $0.02

Consensus EPS
(Jul. 29)
$3.09

Last Year's Q3 EPS
(7/31/2020)
$2.34

Read Call Transcript

Listen to Call

Latest SEC 10-Q Filing

Earnings Per Share Revenue

AbbVie Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AbbVie Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AbbVie (NYSE:ABBV) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2021	3	$2.79	$3.02	$2.90
Q2 2021	3	$3.06	$3.24	$3.13	$3.050-3.090
Q3 2021	3	$3.15	$3.27	$3.21
Q4 2021	3	$3.36	$3.47	$3.40
FY 2021	12	$12.36	$13.00	$12.65
Q1 2022	2	$3.13	$3.29	$3.21
Q2 2022	2	$3.31	$3.54	$3.43
Q3 2022	2	$3.62	$3.73	$3.68
Q4 2022	2	$3.59	$3.91	$3.75
FY 2022	8	$13.65	$14.47		$14.06

ABBV Earnings Information

AbbVie last announced its earnings data on July 29th, 2021. The reported $3.11 earnings per share for the quarter, beating the consensus estimate of $3.09 by $0.02. The firm had revenue of $13.96 billion for the quarter, compared to the consensus estimate of $13.64 billion. Its revenue for the quarter was up 33.9% compared to the same quarter last year. AbbVie has generated $10.56 earnings per share over the last year ($3.71 diluted earnings per share) and currently has a price-to-earnings ratio of 28.9. Earnings for AbbVie are expected to grow by 9.97% in the coming year, from $12.64 to $13.90 per share. AbbVie has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 29th, 2021 based off prior year's report dates.

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/29/2021 (Estimated)
7/29/2021	6/30/2021	$3.09	$3.11	+$0.02	$5.80	$13.64 billion	$13.96 billion
4/29/2021	3/31/2021	$2.83	$2.95	+$0.12	$3.91	$12.84 billion	$13.01 billion
2/2/2021	12/31/2020	$2.85	$2.92	+$0.07	$5.83	$13.70 billion	$13.86 billion
10/30/2020	9/30/2020	$2.75	$2.83	+$0.08	$4.37	$12.71 billion	$12.88 billion
7/31/2020	6/30/2020	$2.20	$2.34	+$0.14	$5.14	$10.14 billion	$10.43 billion
5/1/2020	3/31/2020	$2.25	$2.42	+$0.17	$2.82	$8.31 billion	$8.62 billion
2/7/2020	12/31/2019	$2.19	$2.21	+$0.02	$2.54	$8.68 billion	$8.70 billion
11/1/2019	Q3 2019	$2.29	$2.33	+$0.04	$3.40	$8.37 billion	$8.48 billion
7/26/2019	Q2 2019	$2.21	$2.26	+$0.05	$4.03	$8.09 billion	$8.26 billion
4/25/2019	Q1 2019	$2.06	$2.14	+$0.08	$2.63	$7.81 billion	$7.83 billion

1/25/2019	12/31/2018	$1.92	$1.90	($0.02)	$5.03	$8.37 billion	$8.31 billion
11/2/2018	9/30/2018	$2.01	$2.14	+$0.13	$2.47	$8.23 billion	$8.24 billion
7/27/2018	6/30/2018	$1.98	$2.00	+$0.02	$2.74	$8.22 billion	$8.28 billion
4/26/2018	Q1 2018	$1.79	$1.87	+$0.08	$2.00	$7.60 billion	$7.93 billion
1/26/2018	Q4 2017	$1.44	$1.48	+$0.04	$2.93	$7.53 billion	$7.74 billion
10/27/2017	Q3 2017	$1.39	$1.41	+$0.02	$1.81	$7.00 billion	$7.00 billion
7/28/2017	Q2 2017	$1.40	$1.42	+$0.02	$1.65	$6.93 billion	$6.94 billion
4/27/2017	Q1 2017	$1.2620	$1.28	+$0.0180	$1.50	$6.49 billion	$6.54 billion
1/27/2017	Q416	$1.20	$1.20		$1.55	$6.92 billion	$6.78 billion
10/28/2016	Q316	$1.21	$1.21		$1.45	$6.55 billion	$6.43 billion
7/29/2016	Q216	$1.20	$1.26	+$0.06	$1.54	$6.20 billion	$6.43 billion
4/28/2016	Q116	$1.14	$1.15	+$0.01	$1.47	$6.03 billion	$5.96 billion
1/29/2016	Q415	$1.12	$1.13	+$0.01	$1.34	$6.41 billion	$6.36 billion
10/30/2015	Q315	$1.08	$1.13	+$0.05	$1.52	$5.90 billion	$4.94 billion
7/24/2015	Q215	$1.06	$1.08	+$0.02	$1.33	$5.60 billion	$5.48 billion
4/23/2015	Q115	$0.85	$0.94	+$0.09	$1.25	$718.50 million	$5.04 billion
1/30/2015	Q414	$0.86	$0.89	+$0.03	$2.29	$5.34 billion	$5.45 billion
10/31/2014	Q3	$0.77	$0.89	+$0.12	$1.47	$4.82 million	$5.02 million
7/25/2014	Q214	$0.76	$0.82	+$0.06	$0.96	$4.70 billion	$4.93 billion
4/25/2014	Q114	$0.68	$0.71	+$0.03	$0.83	$4.33 billion	$4.56 billion
1/31/2014	Q4 2013	$0.83	$0.82	($0.01)	$0.94	$5.10 billion	$5.11 billion
10/25/2013	Q3 2013	$0.78	$0.82	+$0.04	$1.04	$4.52 billion	$4.66 billion
7/26/2013	Q2 2013	$0.79	$0.82	+$0.03	$0.98	$4.54 billion	$4.69 billion
4/26/2013	Q1 2013	$0.66	$0.68	+$0.02	$0.76	$4.17 billion	$4.33 billion

(Earnings results data provided by Zacks Investment Research)

AbbVie (NYSE:ABBV) Earnings Frequently Asked Questions

When is AbbVie's earnings date?: AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 29th, 2021 based off last year's report dates. Learn more on ABBV's earnings history
Did AbbVie beat their earnings estimates last quarter?: In the previous quarter, AbbVie (NYSE:ABBV) reported $3.11 earnings per share (EPS) to beat the analysts' consensus estimate of $3.09 by $0.02. Learn more on ABBV's earnings details
How can I listen to AbbVie's earnings conference call?: The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call
How can I read AbbVie's conference call transcript?: The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript
How can I view AbbVie's earnings report?: AbbVie's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does AbbVie generate each year?: AbbVie (NYSE:ABBV) has a recorded annual revenue of $45.80 billion.
How much profit does AbbVie generate each year?: AbbVie (NYSE:ABBV) has a recorded net income of $4.62 billion. ABBV has generated $10.56 earnings per share over the last four quarters.
What is AbbVie's price-to-earnings ratio?: AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 28.86 and a forward price-to-earnings ratio of 8.47. The price/earnings-to-growth ratio is 2.01.
What is AbbVie's EPS forecast for next year?: AbbVie's earnings are expected to grow from $12.64 per share to $13.90 per share in the next year, which is a 9.97% increase.

This page was last updated on 9/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.